Designing a Substance Misuse Data Dashboard for Overdose Fatality Review Teams

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the National Institutes of Health, National Institute on Drug Abuse [R01DA051464] and the Department of Medicine, of the University of Wisconsin School of Medicine and Public Health [233-AAM7146]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the UW-Madison Department of Medicine.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research was reviewed and approved by the Institutional Review Board (IRB) at the University of Wisconsin, Madison (IRB number 2023-1091).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes